Synchrony 2022: Roundtable Discussion on the Pathways and the Challenges of Getting Medications FDA Approved

Gabriel Belfort; Heer Nanda; John C Slattery; Joanna Sambor; John Rodakis; Richard E Frye

doi:10.3390/jpm13050779

Synchrony 2022: Roundtable Discussion on the Pathways and the Challenges of Getting Medications FDA Approved

J Pers Med. 2023 Apr 30;13(5):779. doi: 10.3390/jpm13050779.

Authors

Gabriel Belfort¹, Heer Nanda², John C Slattery³, Joanna Sambor⁴, John Rodakis⁵, Richard E Frye⁶

Affiliations

¹ Axial Therapeutics, Woburn, MA 01801, USA.
² University of California, Berkeley, CA 94720, USA.
³ BioROSA Technologies, Inc., Watertown, MA 02472, USA.
⁴ MapLight Therapeutics, Redwood City, CA 94063, USA.
⁵ N of One: Autism Research Foundation, Dallas, TX 75206, USA.
⁶ Autism Discovery and Treatment Foundation, Phoenix, AZ 85050, USA.

Abstract

The BRAIN Foundation (Pleasanton, CA, USA) hosted a medicine conference, Synchrony 2022, for research into treatments to benefit individuals with neurodevelopmental disorders (NDDs), including autism spectrum disorders (ASD) [...].

Publication types

Editorial